Privia Health Group (PRVA) Earnings Analysis

Privia Health Group (PRVA) has no confirmed upcoming earnings date. Last quarter (2026-02-26) it beat with EPS 0.07 USD vs 0.04 USD est (+75%). It has beaten estimates in 1/6 recent quarters (17%). Trailing P/E 143.41.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does PRVA next report earnings?

No confirmed upcoming earnings date is currently scheduled for PRVA. This page updates as the calendar is published.

PRVA earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-260.07 USD0.04 USD+75%Beat
2025-11-060.05 USD0.06 USD-16.7%Miss
2025-05-080.03 USD0.06 USD-50%Miss
2025-02-270.03 USD0.05 USD-40%Miss
2024-11-070.03 USD0.05 USD-40%Miss
2024-08-080.03 USD0.05 USD-40%Miss

Beat rate: 1/6 (17%) over reported quarters with consensus data.

PRVA valuation and analyst view

Trailing P/E143.41
Trailing EPS0.17529 USD
Price / book4.18
Dividend yield0.00%
Market cap3.21B
Analyst consensusBuy (20 buy / 2 hold / 0 sell)
Avg price target24 USD

Related research pages

Frequently asked questions

When is Privia Health Group (PRVA)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for PRVA. This page updates as the calendar is published.

Did PRVA beat earnings last quarter?

In its 2026-02-26 report, PRVA posted EPS of 0.07 USD versus a 0.04 USD estimate — a beat of 75%.

What is PRVA's earnings track record?

Over the last 6 reported quarters with consensus data, PRVA beat estimates 1 times (17%).

What is PRVA's current P/E ratio and EPS?

PRVA trades at a trailing P/E of 143.41 on trailing EPS of 0.17529177708150429 USD.

What do analysts rate PRVA?

Analyst consensus is "Buy" across 22 ratings (0 strong buy, 20 buy, 2 hold, 0 sell, 0 strong sell). Average 12-month price target: 24 USD.